At 90 days, we observed a nonsignificant trend toward higher PPF rates among GLP-1RA users (OR: 1.65; 95% CI: 0.97–2.81), which progressed to a statistically significant elevation by 1 year (OR: 2.06; 95% CI: 1.17–3.62), driven primarily by TKA, with no clear effect in THA.
← all excerpts
Glucagon-Like Peptide-1 Receptor Agonists in Hip and Knee Arthroplasty: A Comprehensive Systematic Review and Meta-Analysis of Perioperative and Postoperative Outcomes.
1
—
—